Progression of Prostate Cancer Despite an Extremely Low Serum Level of Prostate-Specific Antigen

被引:19
|
作者
Lee, Dong Kil [1 ]
Park, Jeong Hyun [1 ]
Kim, Jae Han [1 ]
Lee, Seung Joon [1 ]
Jo, Moon Ki [1 ]
Gil, Myung Cheol [1 ]
Song, Kang Hyon [1 ]
Park, Jong Wook [1 ]
机构
[1] Korea Canc Ctr Hosp, Dept Urol, 215-4 Gongneung Dong, Seoul 139706, South Korea
关键词
Disease progression; Multiple organ failure; Neoplasm metastasis; Prostate-specific antigen; Prostatic neoplasms;
D O I
10.4111/kju.2010.51.5.358
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
A 61-year-old man who had been diagnosed with prostate cancer 9 years ago and had been treated with pelvic irradiation and intermittent androgen deprivation therapy visited the emergency room because of back pain and weakness in both legs. Spine magnetic resonance imaging showed a lumbar epidural mass and spine metastasis. The whole-body workup revealed multiple metastases to the lymph nodes, bone, liver, and lung. The serum prostate-specific antigen was 0.02 ng/ml. He underwent laminectomy, posterior fixation, and epidural mass excision, and metastatic adenocarcinoma from the prostate was diagnosed. The patient underwent 1 cycle of docetaxel-based chemotherapy. More chemotherapy could not be done because of his general weakness. The patient died one month later of multiple organ failure.
引用
收藏
页码:358 / 361
页数:4
相关论文
共 50 条
  • [1] Prostate cancer progression in the presence of undetectable or low serum prostate-specific antigen level
    Leibovici, Dan
    Spiess, Philippe E.
    Agarwal, Piyush K.
    Tu, Shi-Ming
    Pettaway, Curtis A.
    Hitzhusen, Kate
    Millikan, Randall E.
    Pisters, Louis L.
    CANCER, 2007, 109 (02) : 198 - 204
  • [2] SERUM PROSTATE-SPECIFIC ANTIGEN AND THE BIOLOGIC PROGRESSION OF PROSTATE-CANCER
    KABALIN, JN
    MCNEAL, JE
    JOHNSTONE, IM
    STAMEY, TA
    UROLOGY, 1995, 46 (01) : 65 - 70
  • [3] Metastatic prostate cancer with normal level of serum prostate-specific antigen
    R. Nishio
    Y. Furuya
    O. Nagakawa
    H. Fuse
    International Urology and Nephrology, 2003, 35 (2) : 189 - 192
  • [4] Prostate cancer in the serum prostate-specific antigen era
    Humphrey, PA
    MAYO CLINIC PROCEEDINGS, 1998, 73 (05) : 489 - 490
  • [5] Postejaculation serum prostate-specific antigen level
    Zisman, A
    Soffer, Y
    Siegel, YI
    Paz, A
    Lindner, A
    EUROPEAN UROLOGY, 1997, 32 (01) : 54 - 57
  • [6] Outcomes and predictive factors of prostate cancer patients with extremely high prostate-specific antigen level
    Kouji Izumi
    Wen-Jye Lin
    Hiroshi Miyamoto
    Chiung-Kuei Huang
    Aerken Maolake
    Yasuhide Kitagawa
    Yoshifumi Kadono
    Hiroyuki Konaka
    Atsushi Mizokami
    Mikio Namiki
    Journal of Cancer Research and Clinical Oncology, 2014, 140 : 1413 - 1419
  • [7] Outcomes and predictive factors of prostate cancer patients with extremely high prostate-specific antigen level
    Izumi, Kouji
    Lin, Wen-Jye
    Miyamoto, Hiroshi
    Huang, Chiung-Kuei
    Maolake, Aerken
    Kitagawa, Yasuhide
    Kadono, Yoshifumi
    Konaka, Hiroyuki
    Mizokami, Atsushi
    Namiki, Mikio
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2014, 140 (08) : 1413 - 1419
  • [8] Free serum prostate-specific antigen and screening for prostate cancer
    Bangma, CH
    Kranse, R
    Schroder, FH
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 275 (11): : 837 - 838
  • [9] Serum free prostate-specific antigen in the diagnosis of prostate cancer
    Leung, HY
    Lai, LC
    Day, J
    Thomson, J
    Neal, DE
    Hamdy, FC
    BRITISH JOURNAL OF UROLOGY, 1997, 80 (02): : 256 - 259
  • [10] Prostatic meningeal carcinomatosis with low serum level of prostate-specific antigen
    Honda, M
    Miyagawa, I
    UROLOGY, 2005, 66 (06) : 13205 - 13206